In contrast to most ADPKD mouse models, which utilize Pkd1-/- null mutants, we explore these mechanisms using a Pkd1 heterozygous genetic model, which could more accurately reflect the aberrant epigenetic regulatory mechanisms that facilitate progression of autosomal dominant disease in humans.48 Here, PKD1 is linked to autosomal dominant polycystic kidney disease.